Exelixis
EXEL
#1694
Rank
$11.94 B
Marketcap
$44.36
Share price
-0.02%
Change (1 day)
23.09%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company